Treatment of advanced hepatocellular carcinoma: beyond sorafenib

被引：18
|
作者：
Meyer, Tim [1 ]
机构：
[1] UCL, UCL Canc Inst, London WC1E 6BT, England
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2018年 / 3卷 / 04期
关键词：
DOUBLE-BLIND; PHASE-3; TRIAL;
D O I：
10.1016/S2468-1253(17)30255-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：218 / 220
页数：4
相关论文
共 50 条
  • [41] Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma
    Takeyama, Hideaki
    Beppu, Toru
    Higashi, Takaaki
    Kaida, Takayoshi
    Arima, Kota
    Taki, Katsunobu
    Imai, Katsunori
    Nitta, Hidetoshi
    Hayashi, Hiromitsu
    Nakagawa, Shigeki
    Okabe, Hirohisa
    Hashimoto, Daisuke
    Chikamoto, Akira
    Ishiko, Takatoshi
    Tanaka, Motohiko
    Sasaki, Yutaka
    Baba, Hideo
    SURGERY TODAY, 2018, 48 (04) : 431 - 438
  • [42] Diarrhea Is a Positive Outcome Predictor for Sorafenib Treatment of Advanced Hepatocellular Carcinoma
    Koschny, Ronald
    Gotthardt, Daniel
    Koehler, Christiane
    Jaeger, Dirk
    Stremmel, Wolfgang
    Ganten, Tom M.
    ONCOLOGY, 2013, 84 (01) : 6 - 13
  • [43] Combining telomerase inhibitors with sorafenib as a treatment strategy in advanced hepatocellular carcinoma
    Uldry, E.
    Faes, S.
    Santoro, T.
    Planche, A.
    Demartines, N.
    Dormond, O.
    BRITISH JOURNAL OF SURGERY, 2016, 103 : 22 - 22
  • [44] Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib
    Choi, Joon-Il
    Imagawa, David K.
    Bhosale, Priya
    Bhargava, Puneet
    Tirkes, Temel
    Seery, Tara E.
    Lall, Chandana
    CLINICAL AND MOLECULAR HEPATOLOGY, 2014, 20 (02) : 218 - 222
  • [45] Impact of HCV treatment in patients with advanced hepatocellular carcinoma on sorafenib.
    Herman, Michael
    Zhang, Yuhua
    Wang, Lisa
    Sim, Hao-Wen
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma
    Hideaki Takeyama
    Toru Beppu
    Takaaki Higashi
    Takayoshi Kaida
    Kota Arima
    Katsunobu Taki
    Katsunori Imai
    Hidetoshi Nitta
    Hiromitsu Hayashi
    Shigeki Nakagawa
    Hirohisa Okabe
    Daisuke Hashimoto
    Akira Chikamoto
    Takatoshi Ishiko
    Motohiko Tanaka
    Yutaka Sasaki
    Hideo Baba
    Surgery Today, 2018, 48 : 431 - 438
  • [47] SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA
    Sacco, P. C.
    De Sanctis, R.
    Quadrini, S.
    Gori, B.
    Del, Signore E.
    Stumbo, L.
    Tedeschi, M.
    Falbo, P. T.
    Fulvi, A.
    Grassi, P.
    Sollami, R.
    Basile, M. L.
    Di Seri, M.
    ANNALS OF ONCOLOGY, 2009, 20
  • [48] Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age
    Miyahara, Koji
    Nouso, Kazuhiro
    Yamamoto, Kazuhide
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (15) : 4151 - 4159
  • [49] Sorafenib for advanced-stage hepatocellular carcinoma
    Tomuleasa, Ciprian
    Cristea, Victor
    Irimie, Alexandru
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (03) : 346 - 347
  • [50] Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age
    Koji Miyahara
    Kazuhiro Nouso
    Kazuhide Yamamoto
    World Journal of Gastroenterology, 2014, (15) : 4151 - 4159
12345